Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CorMedix Inc (NYSE MKT LLC:CRMD)

During the Trading Day
2.74 -0.22 / -7.43%
As of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
2.74 -0.003 / -0.11%
 
Volume: 5.9K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$101.3M

Company Description

CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, specifically in the dialysis and non-dialysis areas. The company's products are Neutrolin CRMD003, Thixotropic Gel CRMD004, Deferiprone CRMD001 and Urine Catalytic Test CRMD002. CorMedix was founded on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
1430 US Highway 206
Bridgewater New Jersey 07921
P:(908) 517-9500
Investor Relations:
(908) 517-9489

Employees

Shareholders

Individual stakeholders8.30%
Mutual fund holders8.01%
Other institutional15.08%

Top Executives

Randy D. MilbyCEO, Director & Head-Investor Relations
Harry O'GradyChief Financial & Accounting Officer
Antony E. PfaffleSecretary, Chief Scientific Officer & Director